Terms: = Brain cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
28 results:
1. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
2. Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in cancer with vhl Loss.
Liu X; Simon JM; Xie H; Hu L; Wang J; Zurlo G; Fan C; Ptacek TS; Herring L; Tan X; Li M; Baldwin AS; Kim WY; Wu T; Kirschner MW; Gong K; Zhang Q
Mol Cell; 2020 Mar; 77(6):1294-1306.e5. PubMed ID: 32023483
[TBL] [Abstract] [Full Text] [Related]
3. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract] [Full Text] [Related]
4. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
[TBL] [Abstract] [Full Text] [Related]
5. BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Fung KM; Hassell L
Mol Neurobiol; 2018 May; 55(5):3718-3724. PubMed ID: 28534272
[TBL] [Abstract] [Full Text] [Related]
6. [Von Hippel-Lindau syndrome - two sides of the same coin].
Páleníková P; Adamcová M; Šturdík I; Ftáčniková B; Copáková L; Payer J
Vnitr Lek; 2016; 62(12):1004-1008. PubMed ID: 28139130
[TBL] [Abstract] [Full Text] [Related]
7. Extraneural hemangioblastoma of the kidney: the challenge for clinicopathological diagnosis.
Wu Y; Wang T; Zhang PP; Yang X; Wang J; Wang CF
J Clin Pathol; 2015 Dec; 68(12):1020-5. PubMed ID: 26201545
[TBL] [Abstract] [Full Text] [Related]
8. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract] [Full Text] [Related]
9. A deletion mutation of the vhl gene associated with a patient with sporadic von Hippel-Lindau disease.
Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
[TBL] [Abstract] [Full Text] [Related]
10. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
11. [Von Hippel-Lindau disease: family study].
González Escobar AB; Morillo Sánchez MJ; García-Campos JM
Arch Soc Esp Oftalmol; 2012 Nov; 87(11):368-72. PubMed ID: 23058196
[TBL] [Abstract] [Full Text] [Related]
12. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.
Mills SA; Oh MC; Rutkowski MJ; Sughrue ME; Barani IJ; Parsa AT
Neuro Oncol; 2012 Aug; 14(8):1097-104. PubMed ID: 22723428
[TBL] [Abstract] [Full Text] [Related]
13. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
Venneti S; Boateng LA; Friedman JR; Baldwin DA; Tobias JW; Judkins AR; Mourelatos Z; Lal P
Brain Pathol; 2012 Jul; 22(4):522-9. PubMed ID: 22082152
[TBL] [Abstract] [Full Text] [Related]
14. Von Hippel-Lindau disease manifesting disseminated leptomeningeal hemangioblastomatosis: surgery or medication?
Zhang Q; Ma L; Li WY; Chen J; Ju Y; Hui XH
Acta Neurochir (Wien); 2011 Jan; 153(1):48-52. PubMed ID: 20938791
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance.
Prasad R; Johnston LB; Savage MO; Martin L; Perry LA; Storr HL
J Endocrinol Invest; 2011 Apr; 34(4):296-9. PubMed ID: 20585202
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract] [Full Text] [Related]
17. Complex juxtapapillary capillary hemangioma: a case report.
Reynolds SA; Shechtman D; Falco L
Optometry; 2008 Sep; 79(9):512-7. PubMed ID: 18722963
[TBL] [Abstract] [Full Text] [Related]
18. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.
Hussein MR
Int J Exp Pathol; 2007 Oct; 88(5):311-24. PubMed ID: 17877533
[TBL] [Abstract] [Full Text] [Related]
19. Central nervous system manifestations in vhl: genetics, pathology and clinical phenotypic features.
Gläsker S
Fam Cancer; 2005; 4(1):37-42. PubMed ID: 15883708
[TBL] [Abstract] [Full Text] [Related]
20. Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence.
Miyagami M; Katayama Y
Brain Tumor Pathol; 2004; 21(2):75-82. PubMed ID: 15700837
[TBL] [Abstract] [Full Text] [Related]
[Next]
